Carbinoxamine maleate 4 mg / pseudoephedrine HCl 60 mg Chewable Tablet
RxNorm 1424307
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1424307 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbinoxamine maleate 4 mg / pseudoephedrine HCl 60 mg Chewable Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Carbinoxamine maleate 4 mg / pseudoephedrine hydrochloride 60 mg Chewable Tablet
(Atom ID: 12332644)
PSN
Prescribable Name (PSN):
Carbinoxamine maleate 4 mg / pseudoephedrine HCl 60 mg Chewable Tablet
(Atom ID: 6368209)
PT
Designated preferred name (PT):
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet
(Atom ID: 11435712)
FN